Venus Medtech (Hangzhou) Inc.

Venus Medtech (Hangzhou) Inc.verified

VMTHF

Price:

$0.298

Market Cap:

$941.75M

Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product ...[Read more]

Industry

Medical - Devices

IPO Date

2021-04-30

Stock Exchange

OTC

Ticker

VMTHF

The ROE as of December 2025 (TTM) for Venus Medtech (Hangzhou) Inc. (VMTHF) is -30.05%

According to Venus Medtech (Hangzhou) Inc.’s latest financial reports and current stock price. The company's current ROE is -30.05%. This represents a change of 144.42% compared to the average of -12.29% of the last 4 quarters.

Venus Medtech (Hangzhou) Inc. (VMTHF) Historical ROE (quarterly & annually)

How has VMTHF ROE performed in the past?

The mean historical ROE of Venus Medtech (Hangzhou) Inc. over the last ten years is -49.11%. The current -30.05% ROE has changed -38.82% with respect to the historical average. Over the past ten years (40 quarters), VMTHF's ROE was at its highest in in the January 2017 quarter at 0%. The ROE was at its lowest in in the December 2017 quarter at -103.93%.

Quarterly (TTM)
Annual

Average

-49.11%

Median

-26.71%

Minimum

-216.53%

Maximum

-4.79%

Venus Medtech (Hangzhou) Inc. (VMTHF) ROE by Quarter and Year

Discovering the peaks and valleys of Venus Medtech (Hangzhou) Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 256.66%

Maximum Annual ROE = -4.79%

Minimum Annual Increase = -80.74%

Minimum Annual ROE = -216.53%

Quarterly (TTM)
Annual
YearROEChange
2024-32.31%34.07%
2023-24.10%-17.81%
2022-29.32%256.66%
2021-8.22%71.50%
2020-4.79%-61.77%
2019-12.54%-80.74%
2018-65.09%-69.94%

Venus Medtech (Hangzhou) Inc. (VMTHF) Average ROE

How has VMTHF ROE performed in the past?

The current ROE of Venus Medtech (Hangzhou) Inc. (VMTHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-28.57%

5-year avg

-19.75%

10-year avg

-49.11%

Venus Medtech (Hangzhou) Inc. (VMTHF) ROE vs. Peers

How is VMTHF’s ROE compared to its peers?

Venus Medtech (Hangzhou) Inc.’s ROE is less than MedX Health Corp (52.66%), less than AVITA Medical, Inc. (27.99%), greater than BICO Group AB (publ) (-7.46%), greater than BICO Group AB (publ) (-7.46%), greater than 3-D Matrix, Ltd. (-129.53%), less than Paxman AB (publ) (1.49%), less than Implanet S.A. (1.51%), less than Jushi Holdings Inc. (99.18%), greater than Molecular Partners AG (-50.31%), greater than Santhera Pharmaceuticals Holding AG (-521.53%),

Build a custom stock screener for Venus Medtech (Hangzhou) Inc. (VMTHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Medtech (Hangzhou) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Venus Medtech (Hangzhou) Inc. (VMTHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Venus Medtech (Hangzhou) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Venus Medtech (Hangzhou) Inc.'s ROE?

How is the ROE calculated for Venus Medtech (Hangzhou) Inc. (VMTHF)?

What is the highest ROE for Venus Medtech (Hangzhou) Inc. (VMTHF)?

What is the 3-year average ROE for Venus Medtech (Hangzhou) Inc. (VMTHF)?

What is the 5-year average ROE for Venus Medtech (Hangzhou) Inc. (VMTHF)?

How does the current ROE for Venus Medtech (Hangzhou) Inc. (VMTHF) compare to its historical average?